Paula Brown Stafford M.P.H. Net Worth

Ms. Paula Brown Stafford M.P.H. biography

Paula Brown Stafford M.P.H. is the Pres, CEO & Chairwoman at Novan Inc.

What is the salary of Ms H?

As the Pres、 CEO & Chairwoman of Novan Inc, the total compensation of Ms H at Novan Inc is 897,864$. There are no executives at Novan Inc getting paid more.

How old is Ms H?

Ms H is 56, she's been the Pres、 CEO & Chairwoman of Novan Inc since . There are 6 older and 6 younger executives at Novan Inc. The oldest executive at Novan Inc is Robert Ingram, 77, who is the Independent Director.

Insiders trading at Novan Inc

Over the last 8 years, insiders at Novan Inc have traded over 72,487$ worth of Novan Inc stock and bought 1,476,993 units worth 9,839,419$ . The most active insiders traders include John W Palmour、Robert J Keegan、Life Sciences Holdings Ltd .... On average, Novan Inc executives and independent directors trade stock every 70 days with the average trade being worth of 4,566$. The most recent stock trade was executed by Machelle Sanders on 27 June 2023, trading 11,553 units of NOVN stock currently worth 4,737$.

What does Novan Inc do?

novan, inc. is a clinical-stage biotechnology company focused on leveraging nitric oxide’s natural antiviral and immunomodulatory mechanisms of action to treat dermatological and oncovirus-mediated diseases. we believe that our ability to conveniently deploy nitric oxide in a solid form, on demand and in localized formulations allows us the potential to significantly improve patient outcomes in a variety of diseases.

Novan Inc executives and stock owners

Novan Inc executives and other stock owners filed with the SEC include:

• Paula Brown Stafford M.P.H.,
  Pres, CEO & Chairwoman
• Paula Brown Stafford,
  Pres, CEO & Chairwoman
• Paula Stafford,
  Chairman of the Board, President, Chief Executive Officer
• John M. Gay CPA,
  CFO & Corp. Sec.
• John M. Gay,
  CFO & Corp. Sec.
• John Gay,
  Chief Financial Officer, Vice President - Finance, Corporate Controller, Corporate Secretary
• Robert Ingram,
  Independent Director
• Jenene Thomas,
  Investors Relation
• Machelle Sanders,
  Independent Director
• John Palmour,
  Independent Director
• Robert Keegan,
  Independent Director
• James Bierman,
  Director
• W. Geer,
  Lead Independent Director
• Stanley Hollenbach BS, J.D.,
  Sr. VP of R&D
• John A. Donofrio Jr.,
  Exec. VP, COO & Pres of EPI Health
• Dr. Tomoko Maeda-Chubachi M.B.A., M.D., Ph.D.,
  Chief Medical Officer
• Brian M. Johnson,
  Chief Commercial Officer
• Elizabeth Messersmith,
  Sr. VP & Chief Devel. Officer
• Stanley Hollenbach BS,J.D.,
  Sr. VP of R&D
• Cole Ikkala,
  Director of Investor Relations, Communications & Bus. Devel.
• Dr. Carri Geer,
  Sr. VP & CTO
• Andrew J. Novak,
  VP of Accounting & Bus. Operations and Chief Accounting Officer
• Brian M. Johnson,
  Chief Commercial Officer
• Life Sciences Holdings Ltd ...,
  
• Sean Murphy,
  Director
• Nathan Stasko,
  President & CSO, Director
• G. Kelly Martin,
  Chief Executive Officer
• William L Hodges,
  Interim Chief Financial Office
• M. Joyce Rico,
  Chief Medical Officer
• F Nealt.D.H. One, Llct.D.H....,
  
• A. Donofrio John,
  EVP, Chief Operating Officer
• Eugene Sun,
  Director
• Jeff N Hunter,
  EVP & Chief Business Officer
• Steven D Skolsky,
  Director